AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Industry:
Vaccine/Drug
Technology:
COVID
Investment Stage:
N/A
Number Of Exists:
N/A
Investor Type:
N/A
Headquarters:
Denmark
Funding Status:
N/A
Employee Number:
N/A
Founded Date:
N/A